% alzhub.org library filter
% Source: https://alzhub.org/research?author=Prins+ND&institution=I4210151833&access=free
% 3 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{prins2021-34044875,
  author  = {Prins, N. D. and Harrison, J. E. and Chu, H. M. and Blackburn, K. and Alam, J. J. and Scheltens, P. and {REVERSE-SD Study Investigators}},
  title   = {{A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.1186/s13195-021-00843-2},
  pmid    = {34044875},
  url     = {https://doi.org/10.1186/s13195-021-00843-2}
}

@article{verberk2021-36098162,
  author  = {Verberk, I. M. W. and Laarhuis, M. B. and van den Bosch, K. A. and Ebenau, J. L. and van Leeuwenstijn, M. and Prins, N. D. and Scheltens, P. and Teunissen, C. E. and others},
  title   = {{Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study}},
  journal = {The lancet. Healthy longevity},
  year    = {2021},
  doi     = {10.1016/s2666-7568(20)30061-1},
  pmid    = {36098162},
  url     = {https://doi.org/10.1016/s2666-7568(20)30061-1}
}

@article{taylor2026-9c23dcf2,
  author  = {Taylor, J. and Alam, J. J. and Gomperts, S. N. and Honig, L. S. and Prins, N. D. and Koubiyr, I. and Chu, H. and Gardner, A. and others},
  title   = {{A Phase 2b randomized clinical trial of the oral p38α inhibitor neflamapimod in dementia with Lewy bodies (DLB)}},
  journal = {Research Square},
  year    = {2026},
  doi     = {10.21203/rs.3.rs-10623740/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-10623740/v1}
}